These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37049555)

  • 1. Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21.
    Shah H; Kramer A; Mullins CA; Mattern M; Gannaban RB; Townsend RL; Campagna SR; Morrison CD; Berthoud HR; Shin AC
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes.
    Lips MA; Van Klinken JB; van Harmelen V; Dharuri HK; 't Hoen PA; Laros JF; van Ommen GJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Dane A; Harms A; Vreeken R; Hankemeier T; Smit JW; Pijl H; Willems van Dijk K
    Diabetes Care; 2014 Dec; 37(12):3150-6. PubMed ID: 25315204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of metabolic health by decreased consumption of branched-chain amino acids.
    Cummings NE; Williams EM; Kasza I; Konon EN; Schaid MD; Schmidt BA; Poudel C; Sherman DS; Yu D; Arriola Apelo SI; Cottrell SE; Geiger G; Barnes ME; Wisinski JA; Fenske RJ; Matkowskyj KA; Kimple ME; Alexander CM; Merrins MJ; Lamming DW
    J Physiol; 2018 Feb; 596(4):623-645. PubMed ID: 29266268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
    Boland BB; Mumphrey MB; Hao Z; Townsend RL; Gill B; Oldham S; Will S; Morrison CD; Yu S; Münzberg H; Rhodes CJ; Trevaskis JL; Berthoud HR
    Mol Metab; 2019 Jul; 25():64-72. PubMed ID: 31126840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
    Meirelles K; Ahmed T; Culnan DM; Lynch CJ; Lang CH; Cooney RN
    Ann Surg; 2009 Feb; 249(2):277-85. PubMed ID: 19212182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PYY/Y2R-Deficient Mouse Responds Normally to High-Fat Diet and Gastric Bypass Surgery.
    Boland B; Mumphrey MB; Hao Z; Gill B; Townsend RL; Yu S; Münzberg H; Morrison CD; Trevaskis JL; Berthoud HR
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30857366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
    Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Prada-Oliveira JA
    Obes Surg; 2022 Dec; 32(12):4023-4032. PubMed ID: 36301409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism.
    Magkos F; Bradley D; Schweitzer GG; Finck BN; Eagon JC; Ilkayeva O; Newgard CB; Klein S
    Diabetes; 2013 Aug; 62(8):2757-61. PubMed ID: 23610059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
    Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
    Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-YY
    Boland BB; Laker RC; O'Brien S; Sitaula S; Sermadiras I; Nielsen JC; Barkholt P; Roostalu U; Hecksher-Sørensen J; Sejthen SR; Thorbek DD; Suckow A; Burmeister N; Oldham S; Will S; Howard VG; Gill BM; Newton P; Naylor J; Hornigold DC; Austin J; Lantier L; McGuinness OP; Trevaskis JL; Grimsby JS; Rhodes CJ
    Mol Metab; 2022 Jan; 55():101392. PubMed ID: 34781035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.